The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way

See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.

REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.83%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $63,789,579.06

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$955.76

▼ -14.21 (-1.46%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Elon Musk Secret Crypto Plot Exposed

From Crypto 101 Media | Ad

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00
11/22/2021	George L. Sing	Director	Sell	2,000	$657.50	$1,315,000.00
11/18/2021	George L. Sing	Director	Sell	4,000	$650.00	$2,600,000.00
11/17/2021	Robert E. Landry	CFO	Sell	681	$645.08	$439,299.48
11/16/2021	Andrew J. Murphy	EVP	Sell	7,167	$647.17	$4,638,267.39
11/16/2021	George L. Sing	Director	Sell	6,000	$656.26	$3,937,560.00
10/1/2021	Arthur F. Ryan	Director	Sell	100	$569.49	$56,949.00
10/1/2021	Marion Mccourt	EVP	Sell	1,000	$576.75	$576,750.00
9/15/2021	N. Anthony Coles	Director	Sell	11,948	$658.98	$7,873,493.04	7,811
9/13/2021	Michael S. Brown	Director	Sell	9,704	$648.16	$6,289,744.64	6,328
9/10/2021	Joseph L. Goldstein	Director	Sell	2,479	$650.00	$1,611,350.00	8,370
8/30/2021	George L. Sing	Director	Sell	1,000	$672.50	$672,500.00
8/26/2021	George L. Sing	Director	Sell	150	$672.00	$100,800.00	43,358
8/23/2021	Joseph J. Larosa	EVP	Sell	3,425	$661.84	$2,266,802.00	23,182
8/18/2021	Leonard S. Schleifer	CEO	Sell	200,000	$650.03	$130,006,000.00
8/18/2021	P. Roy Vagelos	Director	Sell	10,039	$650.04	$6,525,751.56
8/13/2021	George L. Sing	Director	Sell	500	$620.00	$310,000.00	47,063
8/11/2021	George L. Sing	Director	Sell	2,000	$620.50	$1,241,000.00	47,063
8/10/2021	Daniel P. Van Plew	EVP	Sell	6,603	$611.86	$4,040,111.58	51,931
8/9/2021	Michael S. Brown	Director	Sell	1,687	$612.38	$1,033,085.06
8/9/2021	Robert E. Landry	CFO	Sell	364	$617.83	$224,890.12
8/5/2021	Bonnie L. Bassler	Director	Sell	2,559	$600.00	$1,535,400.00	3,450
8/5/2021	George D. Yancopoulos	Insider	Sell	50,000	$600.06	$30,003,000.00	937,483
8/2/2021	Marion Mccourt	EVP	Sell	1,000	$577.12	$577,120.00	18,038
7/6/2021	Joseph J. Larosa	EVP	Sell	3,398	$580.00	$1,970,840.00	23,182
7/1/2021	Arthur F. Ryan	Director	Sell	100	$564.50	$56,450.00	23,589
6/25/2021	Michael S. Brown	Director	Sell	2,084	$549.00	$1,144,116.00	2,975
6/21/2021	George D. Yancopoulos	Insider	Sell	80,000	$538.90	$43,112,000.00	987,483
6/14/2021	Arthur F. Ryan	Director	Sell	100	$524.76	$52,476.00	23,673
5/7/2021	Marion Mccourt	EVP	Sell	1,000	$495.63	$495,630.00	18,038

“Crash Insurance” For Your Retirement

From Unstoppable Prosperity | Ad

When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.

Click here to register for free.

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	Cozad Asset Management Inc.	3,421	$3.29M	0.3%	-6.0%	0.003%
5/8/2024	Sheets Smith Wealth Management	1,058	$1.02M	0.1%	+131.5%	0.001%
5/8/2024	Bleakley Financial Group LLC	14,380	$13.84M	0.4%	+60.2%	0.013%
5/8/2024	Heritage Wealth Advisors	32	$31K	0.0%	-72.4%	0.000%
5/8/2024	ProShare Advisors LLC	125,203	$120.51M	0.3%	+20.9%	0.114%
5/8/2024	Cognios Beta Neutral Large Cap Fund LP	560	$0.54M	0.7%	-17.4%	0.001%
5/8/2024	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	23,192	$22.32M	0.2%	-1.1%	0.021%
5/8/2024	US Bancorp DE	5,010	$4.82M	0.0%	+1.4%	0.005%
5/8/2024	Russell Investments Group Ltd.	128,511	$123.71M	0.2%	+6.2%	0.117%
5/8/2024	Washington Trust Advisors Inc.	30,696	$29.55M	2.7%	-4.7%	0.028%
5/8/2024	QRG Capital Management Inc.	21,502	$20.70M	0.3%	+4.8%	0.020%
5/8/2024	Headlands Technologies LLC	845	$0.81M	0.2%	-32.0%	0.001%
5/8/2024	Williams Jones Wealth Management LLC.	1,779	$1.71M	0.0%	+3.4%	0.002%
5/8/2024	Delta Financial Advisors LLC	1,395	$1.34M	0.5%	+1.1%	0.001%
5/7/2024	Verus Capital Partners LLC	326	$0.31M	0.0%	+25.9%	0.000%
5/7/2024	Meeder Advisory Services Inc.	1,317	$1.27M	0.1%	+4.1%	0.001%
5/7/2024	Meeder Asset Management Inc.	241	$0.23M	0.0%	N/A	0.000%
5/7/2024	NorthRock Partners LLC	263	$0.25M	0.0%	-22.9%	0.000%
5/7/2024	Choate Investment Advisors	495	$0.48M	0.0%	-10.8%	0.000%
5/7/2024	Sei Investments Co.	24,407	$23.49M	0.0%	+8.1%	0.022%
5/7/2024	GW Henssler & Associates Ltd.	19,453	$18.72M	1.1%	-2.5%	0.018%
5/7/2024	Concurrent Investment Advisors LLC	794	$0.76M	0.0%	+122.4%	0.001%
5/7/2024	Nixon Peabody Trust Co.	536	$0.52M	0.0%	N/A	0.000%
5/7/2024	Atomi Financial Group Inc.	382	$0.37M	0.0%	+16.8%	0.000%
5/7/2024	Montag A & Associates Inc.	947	$0.91M	0.0%	+2.2%	0.001%
5/7/2024	Susquehanna Fundamental Investments LLC	1,280	$1.23M	0.1%	N/A	0.001%
5/7/2024	Tectonic Advisors LLC	751	$0.72M	0.1%	-4.1%	0.001%
5/7/2024	Swiss National Bank	320,800	$308.77M	0.2%	-3.9%	0.292%
5/7/2024	Forsta AP Fonden	22,900	$22.04M	0.2%	+14.5%	0.021%
5/7/2024	Illinois Municipal Retirement Fund	26,828	$25.82M	0.4%	-1.9%	0.024%
5/7/2024	Nvwm LLC	979	$0.94M	0.3%	+9.4%	0.001%
5/7/2024	Oppenheimer & Co. Inc.	10,259	$9.87M	0.2%	-15.4%	0.009%
5/7/2024	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	1,899	$1.83M	0.1%	+13.9%	0.002%
5/7/2024	Brooklyn Investment Group	484	$0.47M	0.2%	-2.8%	0.000%
5/7/2024	Wealthspire Advisors LLC	484	$0.47M	0.0%	-10.0%	0.000%
5/7/2024	Empowered Funds LLC	1,353	$1.30M	0.0%	+34.5%	0.001%
5/7/2024	AIA Group Ltd	6,888	$6.63M	0.2%	+45.9%	0.006%
5/6/2024	Envestnet Portfolio Solutions Inc.	1,588	$1.53M	0.0%	+33.7%	0.001%
5/6/2024	Empirical Finance LLC	1,976	$1.90M	0.1%	-0.6%	0.002%
5/6/2024	OLD Second National Bank of Aurora	2,998	$2.89M	0.7%	-1.7%	0.003%
5/6/2024	Advisory Services Network LLC	4,588	$4.42M	0.1%	-2.3%	0.004%
5/6/2024	Grandfield & Dodd LLC	32,277	$31.07M	2.0%	+0.2%	0.029%
5/6/2024	Texas Permanent School Fund Corp	21,846	$21.03M	0.2%	-1.3%	0.020%
5/4/2024	Geneos Wealth Management Inc.	846	$0.81M	0.0%	-2.1%	0.001%
5/4/2024	9258 Wealth Management LLC	215	$0.21M	0.0%	N/A	0.000%
5/4/2024	Team Hewins LLC	451	$0.43M	0.1%	+2.5%	0.000%
5/4/2024	Csenge Advisory Group	449	$0.43M	0.0%	+12.3%	0.000%
5/3/2024	Signaturefd LLC	2,250	$2.17M	0.0%	+5.8%	0.002%
5/3/2024	FDx Advisors Inc.	292	$0.28M	0.0%	-70.3%	0.000%
5/3/2024	Catalina Capital Group LLC	250	$0.24M	0.1%	N/A	0.000%
5/3/2024	TFB Advisors LLC	691	$0.62M	0.2%	+85.3%	0.001%
5/3/2024	Mediolanum International Funds Ltd	12,866	$12.43M	0.2%	N/A	0.012%
5/3/2024	Smithbridge Asset Management Inc. DE	3,875	$3.73M	0.8%	-4.8%	0.004%
5/3/2024	Larson Financial Group LLC	50	$48K	0.0%	-20.6%	0.000%
5/3/2024	Callan Capital LLC	303	$0.29M	0.0%	N/A	0.000%
5/3/2024	Mcdonald Capital Investors Inc. CA	141,013	$135.72M	8.5%	-1.8%	0.128%
5/3/2024	WealthTrust Asset Management LLC	772	$0.74M	0.6%	N/A	0.001%
5/3/2024	General American Investors Co. Inc.	14,576	$14.03M	1.0%	-12.1%	0.013%
5/3/2024	Rehmann Capital Advisory Group	601	$0.58M	0.0%	+14.5%	0.001%
5/3/2024	Chevy Chase Trust Holdings LLC	242,380	$233.29M	0.8%	-2.9%	0.221%
5/3/2024	Commerce Bank	6,246	$6.01M	0.0%	+0.5%	0.006%
5/3/2024	AA Financial Advisors LLC	302	$0.29M	0.1%	N/A	0.000%
5/3/2024	BI Asset Management Fondsmaeglerselskab A S	4,779	$4.60M	0.1%	+6.3%	0.004%
5/3/2024	Central Pacific Bank Trust Division	742	$0.72M	0.1%	N/A	0.001%
5/3/2024	Nikko Asset Management Americas Inc.	33,305	$32.04M	0.3%	-4.9%	0.030%
5/3/2024	Whittier Trust Co. of Nevada Inc.	135	$0.13M	0.0%	-18.2%	0.000%
5/2/2024	Chase Investment Counsel Corp	607	$0.58M	0.2%	N/A	0.001%
5/2/2024	Jennison Associates LLC	33,521	$32.26M	0.0%	N/A	0.031%
5/2/2024	Mutual of America Capital Management LLC	13,938	$13.42M	0.1%	-2.7%	0.013%
5/2/2024	FORA Capital LLC	7,324	$7.05M	0.6%	N/A	0.007%
5/2/2024	FinTrust Capital Advisors LLC	2,023	$1.95M	0.4%	-3.0%	0.002%
5/2/2024	Daiwa Securities Group Inc.	17,201	$16.56M	0.1%	+14.0%	0.016%
5/2/2024	Graypoint LLC	2,134	$2.05M	0.1%	+2.0%	0.002%
5/2/2024	Haverford Trust Co	280	$0.27M	0.0%	-18.6%	0.000%
5/2/2024	Quent Capital LLC	390	$0.38M	0.0%	+5.1%	0.000%
5/2/2024	Gilbert & Cook Inc.	1,932	$1.86M	0.3%	+1.3%	0.002%
5/2/2024	Nordea Investment Management AB	29,195	$28.22M	0.0%	+23.2%	0.027%
5/2/2024	Almanack Investment Partners LLC.	5,407	$5.20M	0.9%	+108.0%	0.005%
5/2/2024	Mendel Money Management	273	$0.26M	0.1%	-200.4%	0.000%
5/2/2024	Fidelis Capital Partners LLC	419	$0.40M	0.1%	+15.1%	0.000%
5/2/2024	BNP Paribas	1,786	$1.72M	0.1%	N/A	0.002%
5/2/2024	Choreo LLC	1,083	$1.04M	0.0%	+3.4%	0.001%
5/2/2024	Tobam	3,575	$3.44M	0.3%	-21.7%	0.003%
5/2/2024	Tokio Marine Asset Management Co. Ltd.	2,683	$2.58M	0.1%	+10.9%	0.002%
5/2/2024	Hollencrest Capital Management	107	$0.10M	0.0%	-68.4%	0.000%
5/2/2024	Hussman Strategic Advisors Inc.	2,100	$2.02M	0.5%	-50.0%	0.002%
5/2/2024	PDS Planning Inc	354	$0.34M	0.0%	+5.0%	0.000%
5/1/2024	STF Management LP	1,789	$1.72M	0.7%	-2.0%	0.002%
5/1/2024	GLOBALT Investments LLC GA	1,062	$1.02M	0.0%	N/A	0.001%
5/1/2024	Paces Ferry Wealth Advisors LLC	514	$0.50M	0.3%	-2.7%	0.000%
5/1/2024	Resonant Capital Advisors LLC	332	$0.32M	0.0%	N/A	0.000%
5/1/2024	Connecticut Wealth Management LLC	1,009	$0.97M	0.1%	+1.3%	0.001%
5/1/2024	1834 Investment Advisors Co.	444	$0.43M	0.1%	-11.0%	0.000%
5/1/2024	Janney Montgomery Scott LLC	26,907	$25.90M	0.1%	+10.7%	0.025%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	121,325	$116.77M	0.2%	-2.4%	0.111%
5/1/2024	BOK Financial Private Wealth Inc.	38	$37K	0.0%	N/A	0.000%
5/1/2024	Braun Stacey Associates Inc.	23,391	$22.51M	0.9%	+8.9%	0.021%
5/1/2024	Mission Wealth Management LP	1,850	$1.78M	0.0%	+292.8%	0.002%
5/1/2024	Sequoia Financial Advisors LLC	1,449	$1.40M	0.0%	-31.0%	0.001%
4/30/2024	Private Advisor Group LLC	4,704	$4.53M	0.0%	-3.7%	0.004%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $955.76

$952.14

$971.86

50 Day Range

MA: $942.67

$883.20

$987.61

52 Week Range

Now: $955.76

$684.80

$998.33

Volume

390,075 shs

Average Volume

495,489 shs

Market Capitalization

$104.91 billion

P/E Ratio

28.24

Dividend Yield

N/A

Beta

0.17

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Michael S Brown (Director)
N Anthony Coles (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
Bank of New York Mellon Corp — 0.81%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.37%
Global Assets Advisory LLC — 0.32%
Swiss National Bank — 0.29%
Sumitomo Mitsui Trust Holdings Inc. — 0.29%
Chevy Chase Trust Holdings LLC — 0.22%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Bank of New York Mellon Corp
Assenagon Asset Management S.A.
Perpetual Ltd
Swiss National Bank
Van ECK Associates Corp
Atlas Capital Advisors LLC
Mn Services Vermogensbeheer B.V.
Chevy Chase Trust Holdings LLC
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Joseph L Goldstein (Director)
Marc Tessier-Lavigne (Director)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
Global Assets Advisory LLC
Principal Financial Group Inc.
Jennison Associates LLC
GuoLine Advisory Pte Ltd
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA
ProShare Advisors LLC
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Simplicity Wealth LLC